Merck Serono CEO Relying On Emerging Markets For Near-Term Sales
This article was originally published in PharmAsia News
Executive Summary
Until Merck Serono's pipeline is restored to a healthy capacity, the Germany drug maker is betting on marketing cancer and fertility drugs in emerging markets, according to President and CEO Belen Garijo.